Only 1.5% of children with acute lymphoblastic leukemia who skipped radiation had a recurrence in the central nervous system, according to a recent trial. The therapy, which is intended to prevent such a recurrence, can have devastating side effects.
For people with colorectal cancer with a specific mutation in the BRAF gene, results from a new clinical trial show that a treatment regimen of three targeted drugs can improve how long they live without increasing their risk of serious side effects.
A large clinical trial showed that adding the immunotherapy drug durvalumab (Imfinzi) to standard chemotherapy can prolong survival in some people with previously untreated advanced small cell lung cancer.
Clinical Trials Information for Patients and Caregivers
The Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland, is America’s largest hospital devoted entirely to clinical research. NCI conducts clinical trials at the NIH Clinical Center through its Center for Cancer Research and Developmental Therapeutics Clinic. This page explains how to find and possibly take part in cancer treatment trials at the NIH Clinical Center.
The randomized phase 3 TMIST study is comparing digital tomosynthesis (3D) mammography and digital (2D) mammography in screening women for breast cancer. Doctors want to know if screening with 3D mammography is better at detecting breast cancer early than 2D mammography.
This phase 2 clinical trial will test the effectiveness of a biological drug that targets a protein produced by some cancers (CA 19-9) for people with primary pancreatic and bile duct cancer and those who have colorectal cancer that has spread to their liver. The drug will be given immediately before and after surgery. The trial is investigating whether this treatment can prevent the disease from coming back after surgery.
This phase 2 study will use positron emission tomography/computed tomography (PET/CT) with radioactive material to try to identify places in the body where prostate cancer has spread. The trial is investigating whether conducting this type of imaging scan before the prostate is surgically removed can predict if prostate cancer will return.
